Advisors Asset Management, Inc. Amylyx Pharmaceuticals, Inc. Transaction History
Advisors Asset Management, Inc.
- $5.23 Billion
- Q4 2024
A detailed history of Advisors Asset Management, Inc. transactions in Amylyx Pharmaceuticals, Inc. stock. As of the latest transaction made, Advisors Asset Management, Inc. holds 3,902 shares of AMLX stock, worth $12,330. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,902
Previous 7,653
49.01%
Holding current value
$12,330
Previous $24,000
41.67%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding AMLX
# of Institutions
142Shares Held
49.1MCall Options Held
281KPut Options Held
438K-
Perceptive Advisors LLC New York, NY6.77MShares$21.4 Million0.85% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA4.64MShares$14.7 Million2.86% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.69MShares$8.51 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.67MShares$8.44 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC2.43MShares$7.67 Million0.0% of portfolio
About Amylyx Pharmaceuticals, Inc.
- Ticker AMLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,533,200
- Market Cap $185M
- Description
- Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...